IMS Inc. Is An Advanced Materials Company
Our goal is to improve both the safety of patients and patient outcomes by preventing healthcare associated infections (HAIs) by enabling safer human-environment interactions. We will leverage our growing portfolio of infection-prevention materials solutions into partnerships, strategic licensing arrangements, and branded products. Our solutions are designed to provide life improving benefits to at-risk patients and to those routinely interacting with them in these high-risk environments.
IMS has pioneered and patented technologies aimed at preventing medical device infections and treating and preventing infections associated with complex wounds. We have also developed performance coatings for various applications including decorative paints, industrial flooring and marine anti-fouling paints. Iasis Molecular Sciences is on a path to providing value added, life improving solutions to treat or mitigate infections and performance coating solutions to enhance many human-environment interactions.
IMS was founded following the discovery that sodium polystyrene sulfonate, a water soluble polymer similar to the FDA-approved therapy Kaexalate, could be used to bind and release antiseptics and provide anti-inflammatory benefits for the treatments of wounds. Later, the concept of using polysulfonates as a delivery platform was leveraged to create a family of formulation modifiers with the ability to render surfaces self-disinfecting.
IMS is located on the Riverpoint Campus in Spokane, WA, within the Innovate Washington incubator. We are situated in the downtown corridor surrounded by Washington State University, Gonzaga University and Eastern Washington University. Iasis Molecular Sciences occupies two fully equipped laboratories, including a wet laboratory, tissue culture, and BSL-2 bacteriology capabilities.